事業提携・ライセンシング・投資・M&A動向(四半期別):Q3 2013...市場調査レポートについてご紹介

【英文タイトル】Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q3 2013 15
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q3 2013 15
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q3 2013 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q3 2013 18
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q3 2013 19
2.4.1 Shoppers Drug Mart Receives Ontario Court Approval for Its Acquisition by Loblaw for US$11.93 Billion 19
2.4.2 Amgen Completes Tender Offer to Acquire Onyx Pharma for up To US$10.4 Billion 21
2.4.3 Community Health Systems to Acquire Health Management Associates for up to US$7.6 Billion 22
2.4.4 Fresenius to Acquire 43 Hospitals from Rhon-Klinikum for US$4.1 Billion 23
2.4.5 Tenet Healthcare Prices Private Placement of Notes Due 2022 for US$2.8 Billion 24
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 25
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q3 2013 25
3.1.1 Top M&A Deals in Q3 2013 26
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q3 2012 – Q3 2013 27
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q3 2013 29
3.2.1 Top Initial Public Offerings in Q3 2013 31
3.2.2 Top Secondary Offerings in Q3 2013 31
3.2.3 Top PIPE Deals in Q3 2013 31
3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q3 2012-Q3 2013 32
3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q3 2012 – Q3 2013 33
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q3 2013 35
3.3.1 Top Venture Financing Deals in Q3 2013 36
3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q3 2013 37
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q3 2013 38
3.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q3 2012 – Q3 2013 39
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Last Four Quarters 41
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q3 2012 – Q3 2013 43
3.4 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q3 2013 44
3.4.1 Top Private Equity Deals in Q3 2013 45
3.4.2 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q3 2012 – Q3 2013 46
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q3 2013 48
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q3 2013 48
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q3 2012 – Q3 2013 50
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q3 2013 52
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q3 2013 54
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q3 2013 54
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q3 2013 55
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q3 2012 – Q3 2013 56
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q3 2012 – Q3 2013 58
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q3 2012 – Q3 2013 59
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q3 2012 – Q3 2013 61
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q3 2013 63
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q3 2013 63
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q3 2012 – Q3 2013 65
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q3 2013 67
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q3 2013 67
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q3 2013 68
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q3 2012 – Q3 2013 69
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q3 2012 – Q3 2013 71
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q3 2012 – Q3 2013 73
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q3 2012 – Q3 2013 74
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q3 2012 – Q3 2013 76
6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 78
6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q3 2012 – Q3 2013 78
6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q3 2012 – Q3 2013 80
6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q3 2012 – Q3 2013 82
6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q3 2012 – Q3 2013 84
6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q3 2012 – Q3 2013 86
6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q3 2012 – Q3 2013 88
6.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q3 2012 – Q3 2013 90
7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 92
7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q3 2013 92
7.1.1 Oncology – Deals of the Quarter 94
7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q3 2013 96
7.2.1 Central Nervous System – Deals of the Quarter 98
7.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q3 2013 101
7.3.1 Infectious Disease – Deals of the Quarter 103
7.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q3 2013 105
7.4.1 Immunology – Deals of the Quarter 107
7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q3 2013 108
7.5.1 Metabolic Disorders – Deals of the Quarter 110
7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q3 2013 112
7.6.1 Cardiovascular – Deals of the Quarter 114
7.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q3 2013 116
7.7.1 Gastrointestinal – Deals of the Quarter 118
7.8 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q3 2013 119
7.8.1 Dermatology – Deals of the Quarter 121
7.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q3 2013 122
7.9.1 Respiratory – Deals of the Quarter 124
7.10 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q3 2013 126
7.10.1 Ophthalmology – Deals of the Quarter 128
8 Deal Summary by Geography 130
8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q3 2013 130
8.1.1 North America – Deals of the Quarter 132
8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q3 2013 135
8.2.1 Europe – Deals of the Quarter 137
8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q3 2013 139
8.3.1 Asia-Pacific – Deals of the Quarter 141
8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q3 2013 144
8.4.1 Rest of the World – Deals of the Quarter 146
9 Pharmaceuticals & Healthcare, Global, Top Advisors 148
9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Last One Year 148
9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Last One Year 150
10 Appendix 152
11 Further Information 156
11.1 Methodology 156
11.2 About GlobalData 157
11.3 Disclosure information 158
11.4 Disclaimer 158


【レポート販売概要】

■ タイトル:事業提携・ライセンシング・投資・M&A動向(四半期別):Q3 2013
■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2013
■ 発行日:2013年11月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162973
■ 調査対象地域:グローバル
  • EQT Corporation:石油・ガスバリューチェーン分析レポート2013
    EQT Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "EQT Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “EQT Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the compan …
  • ゴム加工用化学薬品の世界市場2015-2019
    About Rubber Processing Chemicals Rubber is a polymer which is classified into two types, natural and synthetic. Natural rubber is extracted from latex, while synthetic rubber is manufactured through chemical processes. Rubber is processed using various chemicals to improve its resistance against heat, sunlight, oxidation, ozone and mechanical stress. Rubber processing chemicals are also integral …
  • RNA干渉(RNAi)治療の世界市場:siRNA、shRNA、ddRNAiアプローチの展望
    RNAi therapies – new study showing you trends, R&D progress, and predicted revenues When will RNAi therapies reach the market? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there. Our 174-page report provides 95 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our …
  • 混合気体の世界市場:酸素混合気体、窒素混合気体、二酸化炭素混合気体、アルゴン混合気体、水素混合気体、特殊ガス混合気体
    MarketsandMarkets projects that the gas mixtures market size is to grow from USD 28.20 Billion in 2015 to USD 36.76 Billion by 2020, at an estimated CAGR of 5.44%. The increasing income and spending capacity of people in developing economies, increasing demand in various applications such as metal fabrication, electronics, medical & healthcare, automotive, and lighting is the major factor driving …
  • 有機ELディスプレイ(OELD)の世界市場2015-2019
    About OLED Display OLEDs are diodes that use organic materials to produce light. The organic material is packed between conductors that are lit up when electricity is passed through them. OLED display units contain many thin films of several types of organic molecules that produce various colors of light. Unlike LCDs, OLEDs do not require backlights and filters because the light emitted is bright …
  • 洗浄用化学品の世界市場:インサイト、市場機会、市場シェア、市場予測
    The global cleaning chemical market is forecasted to grow around $55.64 billion at a CAGR of 4.7% during 2016-2022. Cleaning chemicals is a kind of chemical agents basically used for cleaning stains, eliminating bas odor, dust particles and other contaminated surfaces. These chemicals can be sanitizer, disinfectants, general purpose cleaner etc. The cleaning chemical market is forecasted to grow a …
  • RFID血液冷蔵庫・冷凍庫の世界市場2016-2020
    About RFID Blood RFID blood storage solutions include blood refrigerators and freezers that are useful in minimizing technical errors and monitoring of blood products. They provide efficient storage and accurate tracking of blood samples, thereby increasing operational efficiency. Technavio’s analysts forecast the global RFID blood refrigerator and freezer market to grow at a CAGR of 22% during th …
  • ホワイトバイオテクノロジーの世界市場分析:製品別(バイオ燃料、バイオマテリアル、生化学、工業用酵素)、用途別(バイオエネルギー、食品・飼料添加物、医薬品原料、パーソナルケア・家庭用品)、セグメント予測
    The global white biotechnology market is expected to reach USD 487.08 billion by 2024, according to a new report by Grand View Research, Inc. Rising awareness and emphasis for the adoption of greener and environment-friendly technologies in various end-use industries is expected to drive the market over the next eight years. Biofuels accounted for over 35% of the market in terms of revenue on acco …
  • インドの農薬市場2016-2020
    Technavio’s research analyst predicts the agrochemical market in India to grow steadily at a CAGR of over 9% during the forecast period. Availability of credit facilities to purchase agrochemicals is the primary driver for the market. The government of India has initiated several policy measures to enable farmers to gain access to credit facilities. These policies emphasize in providing timely and …
  • 工業用クラウドソリューションの世界市場2016-2020
    About Industrial Cloud The industrial cloud is all about using information technologies to manage end-to-end production processes in heavy industries and manufacturing units. Industrial cloud solutions are designed and developed to aid the manufacturing process in the shop floor. The data generated during manufacturing and production processes should be efficiently managed and can yield insights t …
  • 世界の海および国境セキュリティ市場(2014 – 2024)
    Summary The Global Maritime and Border Security Market 2014-2024 Report published by Strategic Defence Intelligence, provides readers with a detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news. Key Findings • The global maritime and border security mar …
  • 世界のIGBTベースのパワーモジュール市場動向(2012-2016)
    TechNavio’s analysts forecast the Global IGBT-based Power Module market to grow at a CAGR of 14.07 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand from renewable energy production. The Global IGBT-based Power Module market has also been witnessing the use of copper wires for interconnections. However, the high cost of IGBT power …
  • New Zealand Oil & Gas Limited:石油・ガスの開発・生産動向及びコスト分析– 2012
    New Zealand Oil & Gas Limited Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary New Zealand Oil & Gas Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
  • 世界の第3のプラットフォーム(Third Platform)市場動向(2012-2016)
    TechNavio's analysts forecast the Global Third Platform market to grow at a CAGR of 12.04 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for cloud services. The market has also been witnessing the introduction of phablets. However, the issues relating to security of cloud services could pose a challenge to the growth of this ma …
  • 世界の粉体塗装(パウダーコーティング)市場(2014-2018)
    About Powder Coatings Powder coatings are a type of solvent-free coating product used to provide a dry finishing process. They They are known to provide a high-quality, durable finish. Moreover, they emit minimal volatile organic compounds and are therefore eco-friendly compared to solvent-based coatings. Powder coatings are composed of resins, additives, curing agents, extenders or fillers, and t …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。